Hide
Show all
Email this article THE USE OF 2% CHLORHEXIDINE GLUCONATE (CHG) AS A DAILY BATHING TO REDUCE BACTEREMIA IN CHILDREN WITH CRITICAL ILLNESS AT PICU/NICU
Abstract
Background: Bacteremia frequently occurs because of nosocomial infection that actually could be preventable. In children who are hospitalized ussually have a higher risk to experience it. Especially in children with critical illness at Pediatric Intensive Care Unit (PICU) at which the state of children to get an indication of central venous catheters (CVC). Objective: To analyze the use of 2% Chlorhexidine Gluconate (CHG) as a daily bathing treatment to reduce bacteremia in critically ill children in the PICU/NICU. Discussion: The study of the use 2% CHG as a daily bathing treatment for critically ill patients admitted to the intensive care unit has been carried out. However, only performed in adult patients. Developing research conducted in children, this study recommends the use of 2% CHG as a daily bathing treatment can be used in selected patients in the NICU when there is an effort by other measures, but still failed to reduce the incidence of CLABSI. Conclusions: Implementation of recommendations will involve approval by the appropriate organizational structure in charge of monitoring the evolution of the practice. Need staff whom known the instructions on the use of CHG to develop procedures daily bathing with 2% CHG in intensive care and decrease the incidence of bacteremia,.
Keywords: Chlorhexidine Gluconate, Daily Bathing, Bacteremia in children, PICU/NICU.
Full Text:
PDFReferences
Bleasdale, S. C., Trick, W. E., Gonzalez, I. M., Lyles, R. D., Hayden, M. K., & Weinstein, R. a. (2007). Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Archives of Internal Medicine, 167(19), 2073–2079. doi:10.1016/S0734-3299(08)79040-3
Climo, M. W., Yokoe, D. S., Warren, D. K., Perl, T. M., Bolon, M., Herwaldt, L. A., … Wong, E. S. (2013). Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection. New England Journal of Medicine, 368(6), 533–542. doi:10.1056/NEJMoa1113849
Derde, L. P. G., Dautzenberg, M. J. D., & Bonten, M. J. M. (2012). Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Medicine, 38(6), 931–939. doi:10.1007/s00134-012-2542-z
Karki, S., & Cheng, A. C. (2012). Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. Journal of Hospital Infection, 82(2), 71–84. doi:10.1016/j.jhin.2012.07.005
Me, R., Rj, C., Lyden, E., Control, I., & Epidemiology, H. (2012). Clinical Summary Clinical Summary : Effect of hospital-wide chlorhexidine patient bathing on healthcare - associated infections Results.
Milstone, A. M., Elward, A., Song, X., Zerr, D. M., Orscheln, R., Speck, K., … Perl, T. M. (2013). Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: A multicentre, cluster-randomised, crossover trial. The Lancet, 381(9872), 1099–1106. doi:10.1016/S0140-6736(12)61687-0
Minnesota, C. H. and C. of M. (2014). CHG bath, 2% chlorhexidine gluconate cloths. Patient family education. Retrieved May 11, 2014, from http://www.childrensmn.org/Manuals/PFS/Surg/206085.pdf
Munoz-Price, L. S., Dezfulian, C., Wyckoff, M., Lenchus, J. D., Rosalsky, M., Birnbach, D. J., & Arheart, K. L. (2012). Effectiveness of stepwise interventions targeted to decrease central catheter-associated bloodstream infections. Critical Care Medicine, 40(5), 1464–9. doi:10.1097/CCM.0b013e31823e9f5b
O’Horo, J. C., Silva, G. L. M., Munoz-Price, L. S., & Safdar, N. (2012). The Efficacy of Daily Bathing with Chlorhexidine for Reducing Healthcare-Associated Bloodstream Infections: A Meta-analysis. Infection Control & Hospital Epidemiology, 33(03), 257–267. doi:10.1086/664496
Onder, A., Chandar, J., Billings, A., Diaz, R., Francoeur, D., Abitbol, C., & Zilleruelo, G. (2009). Chlorhexidine-based antiseptic solutions effectively reduce catheter-related bacteremia. Pediatr Nephrol, (24), 1741–1747.
Popovich, K. J., Hota, B., Hayes, R., Weinstein, R. a, & Hayden, M. K. (2009). Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infection Control and Hospital Epidemiology : The Official Journal of the Society of Hospital Epidemiologists of America, 30(10), 959–963. doi:10.1086/605925
Quach, C., Milstone, A. M., Perpete, C., Bonenfant, M., Moore, D. L., & Perreault, T. (2014a). Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections. Infection Control and Hospital Epidemiology, 35(2), 158–163. doi:10.1086/674862
Quach, C., Milstone, A. M., Perpete, C., Bonenfant, M., Moore, D. L., & Perreault, T. (2014b). Chlorhexidine Bathing in a Tertiary Care Neonatal Intensive Care Unit: Impact on Central Line-Associated Bloodstream Infections. Infect Control Hosp Epidemiol, (35), 158–163.
Sievert, D., Armola, R., & Halm, M. a. (2011). Chlorhexidine gluconate bathing: Does it decrease hospital-acquired infections? American Journal of Critical Care, 20(2), 166–170. doi:10.4037/ajcc2011841
Tamma, P. D., Aucott, S. W., & Milstone, A. M. (2010). Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infection Control and Hospital Epidemiology : The Official Journal of the Society of Hospital Epidemiologists of America, 31(8), 846–9. doi:10.1086/655017
United States Food and Drug Administration. (2012). 2% Chlorhexidine Gluconate (CHG) Cloth. Safety labeling changes approved by FDA Center for Drug Evaluation and Research. Retrieved May 11, 2014, from http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm307387.htm
DOI: http://dx.doi.org/10.30659/nurscope.2.1.1-11
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.